Biotech Values

[DewDiligence]

New ReadMeFirst for OctoPlus…

Democritus_of_Abdera, an assistant moderator on the SRDX board, has compiled a ReadMeFirst for the Dutch biotech company, OctoPlus (OCTO.AS), which has a relationship with SRDX. The RMF is at #msg-33431301. A button pointing to latest version of the RMF will be kept in the iBox of the Biotech Values board and the SRDX board.

I’ve followed OctoPlus cursorily for the past couple of years because of the Locteron program in HCV (#msg-33467893). Lately, the share price has taken a dive that strikes me as an overreaction based on fundamentals. (This is a familiar story these days for small, pre-commercial biotech companies.)

Feel free to comment on OctoPlus either here or on the SRDX board.